(Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q3)Aug 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -16.79%-160.86K | 92.44%-13.56K | 17.97%-713.27K | -296.36%-235.65K | 1.23%-160.35K | -18.97%-137.74K | 66.25%-179.53K | -160.14%-869.5K | -8.51%-59.45K | -109.85%-162.35K |
Net income from continuing operations | 245.69%538.15K | 15.51%-868.75K | 18.56%-2.68M | -28.12%-611.69K | -135.18%-667.4K | 93.70%-369.39K | -130.80%-1.03M | -512.63%-3.29M | -124.14%-477.43K | 57.17%-283.78K |
Operating gains losses | ---- | ---- | ---- | ---- | 510.57%17.21K | ---- | ---- | 75.60%-166.74K | --0 | -99.39%2.82K |
Depreciation and amortization | -30.02%2.01K | 0.00%2.87K | -47.37%11.46K | -47.37%2.87K | -47.35%2.87K | -47.41%2.87K | -47.36%2.87K | 27.35%21.78K | 4.63%5.45K | 0.98%5.45K |
Asset impairment expenditure | ---- | ---- | --66.47K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Unrealized gains and losses of investment securities | -383.33%-646.17K | -16.67%760.2K | -21.72%2.01M | 0.00%304.08K | 251.82%570.15K | -96.02%228.06K | 125.20%912.24K | 445.74%2.57M | 140.85%304.08K | --162.06K |
Remuneration paid in stock | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 76.47%160.71K | --0 | --0 |
Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -72.48%18.79K | --0 | --0 |
Change In working capital | -687.83%-54.85K | 238.80%92.12K | 32.39%-128.99K | -89.64%11.23K | -70.15%-83.18K | 20.62%9.33K | 74.28%-66.37K | -376.54%-190.78K | 52.68%108.45K | -442.02%-48.89K |
-Change in receivables | -272.67%-22.35K | 416.79%132.86K | -513.04%-136.87K | -226.80%-32.13K | -105.99%-56.81K | -124.57%-6K | 5.75%-41.94K | -638.78%-22.33K | 1,170.76%25.34K | -648.18%-27.58K |
-Change in payables and accrued expense | -312.04%-32.5K | -66.80%-40.75K | 104.68%7.89K | -47.83%43.36K | -23.76%-26.37K | 191.93%15.33K | 88.56%-24.43K | -359.78%-168.45K | 20.39%83.11K | -218.52%-21.31K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -33.46%-160.86K | 92.44%-13.56K | 17.97%-713.27K | -296.36%-235.65K | -9.37%-177.56K | -4.10%-120.53K | 66.25%-179.53K | -160.14%-869.5K | -8.51%-59.45K | -109.85%-162.35K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -113.83%-174.23K | 0 | -101.57%-14.23K | -27.29%1.26M | -95.43%54K | 1,397.67%906.66K | ||||
Capital expenditure reported | ---- | ---- | 93.31%-14.23K | ---- | ---- | ---- | ---- | -0.14%-212.79K | ---- | ---- |
Net PPE purchase and sale | ---- | ---- | ---- | ---- | 86.06%-14.23K | ---- | ---- | ---- | ---- | -46.04%-102.04K |
Net business purchase and sale | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
Net investment purchase and sale | ---- | ---- | -110.71%-160K | -396.30%-160K | ---- | ---- | ---- | 26.57%1.49M | -95.42%54K | --964.07K |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -109.31%-74.51K | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | -114.45%-174.23K | --0 | -101.57%-14.23K | ---- | ---- | -30.41%1.21M | --0 | 1,397.67%906.66K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 3,042.55%1.96M | 1.98M | 0 | |||||
Net common stock issuance | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --2M | ---- | ---- |
Cash dividends paid | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 66.78%-20K | --0 | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -191.29%-18.79K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 3,042.55%1.96M | --1.98M | --0 |
Net cash flow | ||||||||||
Beginning cash position | -20.70%2.76M | -24.21%2.78M | 168.03%3.67M | 72.84%3.01M | 220.79%3.21M | 166.91%3.49M | 168.03%3.67M | 3,771.24%1.37M | 625.93%1.74M | 157.91%999.14K |
Current changes in cash | 40.23%-167.68K | 92.44%-13.56K | -138.62%-887.5K | -112.26%-235.65K | -125.77%-191.79K | 8.57%-280.53K | -191.96%-179.53K | 72.49%2.3M | 70.48%1.92M | 605.55%744.31K |
End cash Position | -18.99%2.6M | -20.70%2.76M | -24.21%2.78M | -24.21%2.78M | 72.84%3.01M | 220.79%3.21M | 166.91%3.49M | 168.03%3.67M | 168.03%3.67M | 625.93%1.74M |
Free cash from | -39.12%-167.68K | 92.44%-13.56K | 32.78%-727.5K | -452.43%-215.14K | 19.70%-212.3K | 50.23%-120.53K | 66.55%-179.53K | -86.24%-1.08M | 25.99%-38.94K | -79.57%-264.38K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.